Vimarsana
Biggest News Aggregation in the World

Page 21 - Core Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Core Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Core Lab Today - Breaking & Trending Today

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022 - Vimarsana News

F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022

Basel, 18 October 2022 Group sales up 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales

Holmes Regional lab tech's been on the job in Melbourne since 1972 - Vimarsana News

Holmes Regional lab tech's been on the job in Melbourne since 1972

Fifty years ago, Pheloicsa "Phlo" Bostick went to work as a medical laboratory technician at Holmes Regional Medical Center. She has no plans to slow down.

Neovasc Inc.: Neovasc Provides Corporate Update Following Clinical Data Release - Vimarsana News

Neovasc Inc.: Neovasc Provides Corporate Update Following Clinical Data Release

New Data Presented on the Neovasc Reducer in Patients With Microvascular Disease Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 20, 2022) - Neovasc Inc. (NASDAQ: NVCN)

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism - Vimarsana News

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism

Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT focusing on small vessels, de-novo coronary lesion treatment enrolled the culminating 114th patient on...

Concept Medical Inc.: TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism - Vimarsana News

Concept Medical Inc.: TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

BIRMINGHAM, England, Sept. 13, 2022 /PRNewswire/ -- Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial